Crescent Capital BDC, Inc. Stock

Equities

CCAP

US2256551092

Closed End Funds

Market Closed - Nasdaq 04:00:00 2024-05-15 pm EDT 5-day change 1st Jan Change
18.11 USD -0.17% Intraday chart for Crescent Capital BDC, Inc. +2.72% +4.20%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 190M Sales 2025 * 180M Capitalization 672M
Net income 2024 * 91M Net income 2025 * 79M EV / Sales 2024 * 3.53 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 3.72 x
P/E ratio 2024 *
7.45 x
P/E ratio 2025 *
8.62 x
Employees -
Yield 2024 *
9.87%
Yield 2025 *
9.8%
Free-Float 87.5%
More Fundamentals * Assessed data
Dynamic Chart
Wells Fargo Adjusts Price Target on Crescent Capital BDC to $18 From $16.50, Maintains Equal-Weight Rating MT
Oppenheimer Adjusts Crescent Capital BDC Price Target to $20 From $19, Maintains Outperform Rating MT
Transcript : Crescent Capital BDC, Inc., Q1 2024 Earnings Call, May 09, 2024
Crescent Capital BDC, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Oppenheimer Adjusts Crescent Capital BDC Price Target to $19 From $18, Maintains Outperform Rating MT
Transcript : Crescent Capital BDC, Inc., Q4 2023 Earnings Call, Feb 22, 2024
Earnings Flash (CCAP) CRESCENT CAPITAL BDC Reports Q4 EPS $0.61 MT
Crescent Capital BDC, Inc. Announces Management Changes CI
Crescent Capital BDC, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Crescent Capital BDC, Inc. Announces A Fourth Quarter 2023 Supplemental Cash Dividend, Payable on March 15, 2024 CI
Crescent Capital BDC, Inc. Declares Regular Cash Dividend for the First Quarter 2024, Payable on April 15, 2024 CI
Wells Fargo Raises Price Target on Crescent Capital BDC to $16.50 From $16, Maintains Equalweight Rating MT
North American Morning Briefing : Caution -2- DJ
Wells Fargo Downgrades Crescent Capital BDC to Equal-Weight From Overweight, Trims Price Target to $16 From $16.50 MT
Transcript : Crescent Capital BDC, Inc., Q3 2023 Earnings Call, Nov 09, 2023
More news
1 day-0.17%
1 week+2.72%
Current month+4.50%
1 month+6.78%
3 months+10.36%
6 months+8.38%
Current year+4.20%
More quotes
1 week
17.91
Extreme 17.91
18.20
1 month
16.93
Extreme 16.93
18.20
Current year
15.91
Extreme 15.91
18.20
1 year
13.37
Extreme 13.37
18.20
3 years
12.55
Extreme 12.55
21.48
5 years
6.21
Extreme 6.21
21.48
10 years
6.21
Extreme 6.21
21.48
More quotes
Managers TitleAgeSince
Chief Executive Officer - 14-12-31
Director of Finance/CFO 50 19-10-09
Compliance Officer - 21-12-31
Members of the board TitleAgeSince
Director/Board Member 68 14-12-31
Director/Board Member 76 18-12-31
Chairman - 21-06-29
More insiders
Date Price Change Volume
24-05-15 18.11 -0.17% 164,907
24-05-14 18.14 +1.11% 344,931
24-05-13 17.94 -1.37% 156,401
24-05-10 18.19 +1.39% 263,713
24-05-09 17.94 +1.76% 263,779

Delayed Quote Nasdaq, May 15, 2024 at 04:00 pm EDT

More quotes
Crescent Capital BDC, Inc. is a specialty finance company focused on lending to middle-market companies. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It invests primarily in secured debt, including first lien, unitranche first lien and second-lien debt, and unsecured debt, including mezzanine and subordinated debt, as well as related equity securities of private United States middle-market companies. It is focused on purchasing interests in loans or make debt investments, either directly from its target companies as primary market or private credit investments (private credit transactions), or primary or secondary market bank loan or high yield transactions in the syndicated market (syndicated loans and bonds). Although its focus is to invest in less liquid private credit transactions. The Company is managed by Crescent Cap Advisors, LLC.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
18.11 USD
Average target price
18.7 USD
Spread / Average Target
+3.26%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW